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Abstract. Recent studies have demonstrated that inhi- 
bition of mevalonate synthesis in cultured cells leads to 
altered cell morphology due to inhibition of protein 
prenylation. To investigate the effects in vivo of meva- 
lonate deprivation in nondividing, terminally differenti- 
ated neural cells, we have analyzed the effects on reti- 
nal tissue of intravitreal injection of lovastatin, a potent 
inhibitor of the mevalonate-producing enzyme, HMG- 
CoA reductase. A single injection of lovastatin (0.25 
~mol) produced profound dysplastic-like changes in 
adult rat retinas primarily involving the photoreceptor 
layer. Within 2 d after injection, photoreceptor nuclei 
migrated in a circular pattern resulting in the formation 
of rosette-like structures by 4 d. Also during this pe- 
riod, photoreceptor inner and outer segment degenera- 
tion was evident. By 21 d, intact photoreceptor nuclei 
with remnants of inner and outer segments were dis- 
persed throughout all retinal layers. To investigate the 
biochemical specificity of the lovastatin-induced alter- 
ations, and to distinguish the relative importance of the 
various branches of the mevalonate pathway, the incor- 
poTation of [3H]acetate into retinal lipids was examined 
in the presence and absence of metabolic inhibitors. 
HPLC analysis of lovastatin-treated retinas revealed a 
dramatic reduction in the incorporation of intravitre- 
ally injected [3H]acetate into nonsaponifiable lipids, 
compared with controls. In contrast, intravitreal injec- 
tion of NB-598, a specific inhibitor of squalene epoxi- 
dase, eliminated the conversion of newly synthesized 
squalene to sterols without obvious pathology. Hence, 
involvement of the sterol branch of isoprenoid metabo- 
lism in the lovastatin-induced morphologic disruption 
was obviated. Intravitreal injection of 0.27 ixmol of 
N-acetyl-S-trans,trans-farnesyl-L-cysteine  (AFC), an 
inhibitor of carboxyl methyltransferase activity and 
prenylated protein function, produced morphologic 
changes that were virtually indistinguishable from 
those induced with lovastatin. These results implicate a 
defect in protein prenylation in the lovastatin-induced 
retinal degeneration, and suggest the presence of a dy- 
namic pathway in the retina that requires isoprenylated 
proteins to maintain retinal cytoarchitecture. 
I 
NHIBITION of mevalonate biosynthesis with 3[3-hydroxy- 
3-methylglutaryl-coenzyme A  (HMG-CoA)  1 reduc- 
tase inhibitors (e.g., lovastatin) prevents the synthe- 
sis of sterols, dolichols, ubiquinone, isopentenyl modified 
tRNA, heme a,  and the prenylation of cellular proteins 
such as the ras  superfamily small  GTP-binding proteins 
(Maltese, 1990; Schroepfer, 1981; Sinensky and Lutz, 1992; 
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1. Abbreviations used in this paper. AFC, N-acetyl-S-trans,trans-farnesyl- 
L-cysteine; HMG CoA, 3[3-hydroxy-3-methylglutaryl-coenzyme  A; inl, in- 
ner nuclear layer; oni, outer nuclear layer; olin, outer limiting membrane; 
ris, rod inner segment; ros, rod outer segment; rpe, retinal pigment epithe- 
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see Fig. 1). Treatment of cultured cells with lovastatin pro- 
duces growth arrest, cell rounding, and an aberrant refrac- 
tile morphology (for reviews see Hall, 1993; Goldstein and 
Brown, 1990). Recent data have suggested a role for the 
apparently ubiquitous rho class of small GTP-binding pro- 
teins in the modulation of cytoskeletal architecture in cul- 
tured mammalian cells  (for review see Nobes and Hall, 
1994). The first compelling evidence for the function of 
rho proteins was obtained by direct microinjection of con- 
stitutively  active  rhoA  protein  into  mouse  fibroblasts 
(Paterson et al., 1990), causing cell rounding that was at- 
tributed to a primary effect on microfilaments. Disruption 
of intermediate filaments appeared to occur as a second- 
ary effect of microfilament dissolution,  while microtubules 
appeared unaffected. Studies done with a  human renal 
carcinoma cell line  provided  independent confirmation 
that microfilament dissolution and changes in cell shape 
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1992). Both rho and rac are prenylated at their COOH- 
termini with a geranylgeranyl isoprenoid. In mouse fibro- 
blasts, rhoA was shown to be required to induce focal ad- 
hesions (Ridley and Hall, 1992), whereas racl was neces- 
sary for membrane ruffling to occur (Ridley et al., 1992). 
Rho and rac were also essential to initiate de novo actin 
polymerization and for entrapment of released cortical fil- 
aments,  respectively, during  activation of rat  peritoneal 
mast cells (Norman et al., 1994). Inhibition of rhoA in neu- 
ronal cells by ADP ribosylation led to a loss of actomyosin 
contractility and promotion of neurite outgrowth (Jalink 
et al., 1994). Thus, at least two members of the rho class of 
ras-like proteins regulate specific aspects of cytoskeletal 
structure and function. 
In the eye, intravitreal injection of [3H]mevalonate re- 
vealed the prenylation of several retina proteins ranging in 
size from 8-100 kD  (Anant et al.,  1992).  These proteins 
have been identified as rod cell cGMP phosphodiesterase 
and 13 subunits (Anant et al., 1992; Qin et al., 1992), rod 
cell transducin ~/subunit (Fukada et al.,  1990; P6rez-Sala 
et al., 1991), rhodopsin kinase (Inglese et al., 1992) and at 
least three proteins in the 20-30-kD range, which have not 
been characterized rigorously. Based on their size, relative 
abundance,  isoprenoid  modification,  methylation,  and 
GTP binding (P6rez-Sala et al.,  1991), the 20-30-kD pro- 
teins are likely to be members of the ras superfamily (for 
review see Hall, 1993). In a preliminary report, we previ- 
ously showed that intravitreal injection of lovastatin into 
adult rat eyes profoundly disrupts retinal cell morphology 
(Pittler et al.,  1992).  Here, we describe in detail the mor- 
phological manifestations of this effect, and provide spe- 
cific evidence that implicates disruption of protein preny- 
lation, rather than other branchpoints of the isoprenoid 
metabolic pathway. 
Materials and Methods 
Adult female Long-Evans pigmented rats (200--250 g) (Harlan Sprague- 
Dawley, Indianapolis, IN,  or  Charles  River Laboratories, Wilmington, 
MA) were maintained for at least one week on cyclic lighting (12 h light, 
12 h dark) before use. All procedures involving animals conformed to the 
Association For Research in Vision and Ophthalmology, Committee on 
Animals in Research (Bethesda, MD; Statement for the Use of Animals in 
Ophthalmic and Vision Research, 1990) and the NIH Guide for the Care 
and Use of Laboratory Animals. [3H]Acetate (Na salt, 27 Ci/mmol) was 
obtained from ICN Radiochemicals (Irvine, CA). 14C-labeled cholesterol 
and squalene were obtained from American Radiolabeled Chemicals (St. 
Louis, MO). Lovastatin (a generous gift of Dr. A. Alberts, Merck Sharpe 
&  Dohme, Rahway, NJ) was converted to the sodium salt (Kita et al., 
1980) and stored lyophilized at -20°C. Just before use the drug was dis- 
solved in 10 mM Tris, pH 7.4 (stock concentration, 20 mg/ml). NB-598 (a 
generous gift of Dr. M. Horie, Banyu Pharmaceutical Co., Ltd., Tokyo, Ja- 
pan) was dissolved in Me2SO (stock concentration, 10 mg/ml) before use. 
N-acetyl-S'trans'trans'farnesyl-L-cysteine  (AFC; Biomol, Inc., Plymouth 
Meeting, PA) was dissolved in Me2SO at a concentration of 30 mg/ml. All 
organic solvents were obtained from Burdick & Jackson (Muskegon, MI). 
Unless otherwise specified, all other analytical reagents and biochemicals 
were obtained from Sigma Chem. Co. (St. Louis, MO). 
Intravitreal Injections 
Intravitreal injections were performed as previously described (Pittler et 
al., 1992; Fliesler et al., 1993). For evaluation of the persistence of the ef- 
fects of lovastatin or NB-598, one eye of each animal (three animals per 
group) was injected with either lovastatin (0.25 p,  mol in 5 p~l Tris-HCl, pH 
7.4) or NB-598 (50 p.g in 5 ~,1 Me2SO); the contraiateral eye received 5 p,l 
of Me2SO alone (control). Animals were injected 1, 3, or 7 d later in both 
eyes with [3H]acetate (0.20-0.25  mCi/eye, in 5 ~1 PBS); after allowing 6 h 
for uptake and metabolism of the radiolabeled precursor, animals were 
enucleated, and the neural retinas were isolated. 
Extraction and Analysis of  Retina 
Nonsaponifutble  Lipids 
The procedures employed for the saponification, extraction, and analysis 
of retinal nonsaponifiable lipids were performed as previously described 
(Keller et al., 1988; Fliesler et at., 1993). The lower limit of detection was 
~10 pmol for cholesterol and ~1 pmol for squalene. The elution positions 
for mass and radioactivity were calibrated using cholesterol and squaiene 
standards. Since the extinction coefficient for squalene at 214 nm is ~10- 
fold greater than  that  of cholesterol, the  relative  integrated  areas  or 
heights of the uv peaks do not correspond directly to the amounts of cho- 
lesterol and squalene mass represented in the chromatograms. Absolute 
retention times for cholesterol and other isoprenoid components varied 
from day to day, due to changes in ambient room temperature. Authentic 
14C-labeled standards of cholesterol and squalene were employed before 
and after each set of HPLC  analyses to verify and calibrate retention 
times. 
Light and Electron Microscopy 
At postinjection intervals ranging from 1 to 21 d, animals were given an 
overdose of sodium pentobarbital and both eyes were enucleated. The 
dissection and fixation protocols used in this study have been previously 
reported (Rapp and Smith, 1992). Briefly, after enucleation, whole eyes 
were immersed in a solution of 2.5% glutaraldehyde and 1% paraformal- 
dehyde buffered with 0.125 M sodium cacodylate, pH 7.35. After 15 min 
the anterior segment was removed and the peripheral one-third of the na- 
sal eyecup was trimmed off by making a cut in the vertical plane of the 
eye. The remaining tissue was fixed overnight at 4°C and post-fixed the 
next day in buffered 1% osmium tetroxide. This was followed by dehydra- 
tion in graded ethanols and embedment in an Embed  ® 812-Araldite 502 
plastic mixture (Electron Microscopy Sciences, Fort Washington, PA). 
Sections for light microscopy were cut at 0.5  Ixm and stained with 1% 
Toluidine  Blue.  For  electron microscopy, 80-90-nm  sections were  cut 
from the same blocks, stained with 5% uranyl acetate and 2% lead citrate, 
and examined with a JEOL 100CX electron microscope. 
Results 
Intravitreal Lovastatin Induces Temporally Distinct 
Changes in Retinal Morphology 
While  numerous  studies  have  analyzed  the  effects  of 
lovastatin on cultured cells, its effect on terminally dif- 
ferentiated tissue  in  vivo has  not  been  examined.  Be- 
cause of its highly organized structure, the retina was a 
model tissue with which to initiate such studies. Prelimi- 
nary  studies  showed  that  the  effects of lovastatin  were 
qualitatively similar for intravitreal injections in the range 
of 0.05--0.25 p,  mol/eye. In contrast, no effects were observed 
below 0.05 p,  mol and panretinal necrosis was observed at 
doses/>0.37 p,  mol (data not shown). 
To identify the progression of morphologic changes in 
the rat retina, several postinjection time points were evalu- 
ated. Control eyes injected with Tris buffer (Fig. 2, A  and 
B) displayed the typical retinal cytoarchitecture and strati- 
fication  as  observed  in  untreated  animals.  Fig.  2,  C-F 
shows morphologic changes near the site of drug deposi- 
tion at 1-2 d after injection. A  gradient of effect was ob- 
served with the area near the site of injection most dis- 
rupted, and more peripheral areas less affected. Peripheral 
areas away from the site of injection were unaffected (not 
shown). At 1 d after injection of lovastatin (Fig. 2, C and 
D), the onl and olm took on a wavy appearance and pho- 
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Figure 1.  The mevalonate  pathway. Mevalonate (derived  from 
acetylCoA) is converted in several steps (indicated by arrows) to 
a five carbon isoprene unit, which is the precursor to all products 
of the various branches of the pathway. The enzymatic steps in- 
hibited by lovastatin, NB-598, and AFC are shown. Side by side 
arrows indicate multiple steps required that are not shown in detail. 
toreceptor nuclei were displaced from their usual position. 
Rod  outer  segments  were  intact,  but  were  misaligned. 
Vacuoles were observed in and around the inl and gcl. At 
2  d  after injection, focal invaginations were observed in 
the onl, consistent with the early stages of rosette forma- 
tion (Fig. 2, E  and F). There was also evidence of ris and 
ros degeneration (i.e., truncation and misalignment). The 
distal ends of the outer segments became oriented towards 
the center of the newly forming rosettes. Rosettes com- 
prised of photoreceptor nuclei were clearly distinguishable 
at 6 d after lovastatin treatment (Fig. 3 A). With the excep- 
tion of compensatory displacement of inl cells, the rpe and 
other retinal cells appeared relatively unaffected. Rosette 
structure was seen as a circular arrangement of photore- 
ceptor cell nuclei in layers of 2-6 cells in thickness (Fig. 3 
B). Macrophages were typically seen in and around the ro- 
settes. By 21 d after injection, photoreceptor nuclei had as- 
sumed  a  more  random  distribution  throughout  the  af- 
fected region (Fig. 3,  C  and D). Despite these dramatic 
changes  in  retinal  organization,  a  surprising  number  of 
photoreceptor  nuclei  persisted  and  no  pyknotic  nuclei 
were observed in any of the retinal layers. Rod inner and 
outer  segments  were  not  detectable  at  the  light  micro- 
scopic level. Retinal vessels showed numerous lumina, in- 
dicating that capillary shunting had occurred. Migration of 
rpe-like pigment  granule  containing cells into the  outer 
retina and  around blood vessels in the inner retina was 
also apparent at the later timepoint (Fig. 3 D) indicating 
possible rpe involvement. 
To provide further insight into the nature of the lova- 
statin-induced  disruption,  electron microscopy was  per- 
formed. Remnants of rod inner and outer segments were 
seen in the interior of rosettes at 6 d after injection (Fig. 4 
A). By 21 d after injection, photoreceptor remnants were 
very sparse (Fig. 4 B). Small packets of rod outer segment 
disks were occasionally observed in close proximity to as- 
sociated nuclei surrounded by minimal cytoplasm contain- 
ing  what  appeared  to  be  mitochondria  and  other  or- 
ganelles. These results indicate that lovastatin treatment is 
not simply leading to cell death, but rather appears to be 
affecting specific aspects of organelle integrity and retinal 
cytoarchitecture. 
Persistence of Lovastatin Inhibitory Activity after 
Lovastatin Injection 
We previously demonstrated short-term inhibition of the 
retina isoprenoid lipid biosynthetic pathway by lovastatin 
upon coinjection with [3H]acetate in rats (Fliesler et al., 
1993), however, we did not examine the persistence of this 
effect. To  determine  the  persistence  of lovastatin  inhi- 
bition  we  evaluated  [3H]acetate  incorporation  in  drug- 
injected and contralateral (control) eyes at 1 or 7 d. The 
corresponding radio-HPLC profiles of the  retina nonsa- 
ponifiable lipids are shown in Fig. 5. In the control (Fig. 5 
A), a prominent, symmetrical peak of radioactivity was co- 
incident with the endogenous cholesterol mass (retention 
time, 10.8 rain). In striking contrast, at both 1 (Fig. 5 B) 
and 7 d (Fig. 5 C) after a single lovastatin treatment, no in- 
corporation of radioactivity into cholesterol was observed. 
In the latter two samples, the total incorporation of radio- 
activity into retina nonsaponifiable lipids was reduced by 
93% and 99%, respectively, relative to the controls. Hence, 
a single intravitreal injection of lovastatin virtually abol- 
ished isoprenoid lipid biosynthesis, and the inhibitory ac- 
tion persisted for at least 7 d. Since HMG-CoA reductase 
(e.g., in rat liver) has a half-life of ~2-3 h  (Dugan et al., 
1972), these  results  further suggest that  lovastatin itself 
persists in the eye at pharmacologically effective levels. 
Inhibition of Sterol Synthesis Does Not Induce 
Histological Changes in the Retina 
To examine the potential involvement of cholesterol dep- 
rivation in the lovastatin-induced pathology, NB-598, a se- 
lective inhibitor of squalene-2,3-epoxidase (Horie et al., 
1990), was intravitreally injected into one eye, while the 
contralateral eye received MeESO  alone.  Morphological 
analysis was then performed at 3 and 7 d  after injection 
(two animals per time point). We previously showed that 
50 Ixg of NB-598 was effective in blocking conversion of 
coinjected [3H]acetate to cholesterol in the rat retina, with 
resulting accumulation of radiolabeled squalene and squa- 
lene mass over a 6-h period (Fliesler et al., !993). Exami- 
nation of the retinas from NB-598-treated eyes revealed 
that their morphology was essentially identical to vehicle- 
injected  controls  (not  shown).  Therefore, either  retinal 
requirements for cholesterol and other sterols are main- 
tained by extra-ocular sources, or else a sufficient endoge- 
nous sterol pool exists in the retina to satisfy cholesterol 
requirements over the 1-wk observation period. However, 
these  results  do not rule out the possibility of recovery 
from NB-598 inhibition of sterol synthesis. To examine the 
persistence of squalene epoxidase inhibition by NB-598, 
rat eyes were injected with [3H]acetate, 3 or 7 d after intra- 
vitreal injection with NB-598 (50 p~g, in 5 ix1 of MeESO) or 
with Me2SO alone. In the series shown, ~75-80%  of the 
total nonsaponifiable radioactivity in controls (Fig. 6 A) 
comigrated with the endogenous cholesterol mass (reten- 
tion time, 13.5  rain). 3 d  after administration of NB-598 
(Fig. 6 B), N80-85% of the total nonsaponifiable radioac- 
tivity was coincident with the elution position of squalene 
Pittler et al. Protein Prenylation and Retinal Cytoarchitecture  433 Figure 2.  Early changes in the structural organization of the retina caused by intravitreal injection of 0.25 p.mol lovastatin. (A and B) 
Control retina from eyes injected with Tris-HC1,  pH 7.4; (C and D) retina 1 d after lovastatin injection; (E and F) retina 2 d after lova- 
statin injection. The micrographs on the fight (B, D, and F) are higher magnifications of representative regions from the lower power 
micrographs on the left (A, C, and E). In D, the outer limiting membrane (arrowheads) follows the wave-like displacement of the outer 
nuclear layer at 1 d after injection. Abbreviations: rpe, retinal pigment epithelium; ros, rod outer segments; r/s, rod inner segments; onl, 
outer nuclear layer; inl, inner nuclear layer. Bars: (A, C, and E) 100 txm; (B, D, and 17) 1 jxm, central inferior region. 
The Journal  of Cell Biology,  Volume 130, 1995  434 Figure 3.  Changes in retinal structure at 6- (A and B) and 21-d (C and D) after intravitreal injection  of 0.25 Ixmol  lovastatin.  Micro- 
graphs B and D are higher magnifications  of A and C, respectively, as in Fig. 1. In A, photoreceptor nuclei have organized into rosettes 
(r) at 6 d after injection. In B, macrophages (arrowheads) are seen in the interior of the rosettes. Rosettes are not seen at 21 d after injec- 
tion (C and D); instead, photoreceptor nuclei are scattered throughout the retina. Retinal vessels (arrows) take on an unusual appear- 
ance with numerous lumina, suggesting that capillary shunting has occurred.  Bars: (A and C) 100 p~m; (B and D) 1 ixm, central inferior 
region. 
(retention time, 15.5 min), whereas only ~4-5% of the ra- 
dioactivity  was  coincident  with  cholesterol.  In  addition, 
whereas squalene mass is virtually undetectable in normal 
rat retinas (cf. Fig. 5, A-C and Fig. 6 A), significant accu- 
mulation of squalene mass was noted, to a level approach- 
ing 5-7 mol %  of the cholesterol mass. At 7 d  after injec- 
tion  with  NB-598  (Fig.  6  C),  radioactivity derived  from 
[3H]acetate  was  still  largely  accumulating  as  squalene, 
while cholesterol only accounted for ~10-12% of the total 
nonsaponifiable  radioactivity.  Also,  the  accumulation  of 
squalene mass was even greater than at the 3-d time point 
(cholesterol:squalene  mole ratio,  ~4:1).  Hence, although 
the inhibitory activity of NB-598 at the given dosage was 
not  quantitative  in this  experiment, significant inhibition 
of squalene epoxidase persisted for at least 7 d after a sin- 
gle  intravitreal  injection  of  NB-598.  Surprisingly,  there 
was no appreciable decrease in total cholesterol mass of 
NB-598-treated retinas, compared with controls. In total, 
these findings indicate that inhibition  of de novo choles- 
terol  synthesis  does  not  underlie  the  lovastatin-induced 
pathology. 
Effects of lntravitreal AFC 
A  direct  link  between  the  observed,  lovastatin-induced 
morphologic changes and inhibition of the function of pre- 
nylated  proteins  was  suggested  by  subsequent  results 
obtained by intravitreal injection of N-acetyl-S-trans,trans- 
farnesyl-L-cysteine  (AFC).  A  dosage  of  0.41  ~mol  dis- 
solved in DMSO was grossly cytotoxic, producing panreti- 
nal necrosis with marked cell loss and gliotic scarring (not 
shown). Injection of 0.07-0.27 izmol produced morpholog- 
ical changes strikingly similar to those observed with lova- 
Pittler et al. Protein Prenylation and Retinal Cytoarchitecture  435 Figure 4.  Electron micrographs 6 (A) and 21 d (B) after injection of 0.25 txmol lovastatin. In A, showing interior of rosette, rod outer 
segment fragments (ros) containing  membranous disks, and portions of rod inner segments (ris) are dearly observed. One photorecep- 
tor nuclei (pn) forming part of the rosette is also seen. In B, most photoreceptor nuclei (pn) are partially or completely surrounded by 
sparse cytoplasm with organelles. Severely truncated stacks of disorganized ros disks (ros) are occasionally seen. Bars: (A) 2 i~m;  (B) 2 txm. 
statin, including rosette formation and migration of pho- 
toreceptor  nuclei  into  other  retinal  layers  (Fig.  7);  in 
contrast, DMSO-injected controls displayed no pathology 
(not shown; cf. Fig. 2, A and B). Taken together, these re- 
suits implicate alteration of prenylated protein function as 
the  primary  cause  of the  lovastatin-  and  AFC-induced 
morphological alterations. 
Discussion 
We have shown that in vivo inhibition of the mevalonate 
pathway leads to  gross disruption of cytoarchitecture in 
the adult rat retina. This is the first study to demonstrate 
an effect of lovastatin in nondividing, terminally differenti- 
ated neural cells in vivo. This is an important distinction 
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Figure  5.  Persistence  of  the 
lovastatin  effect.  Reverse- 
phase  HPLC  radiochromato- 
grams of control (A) and lov- 
astatin-treated (B  and  C)  rat 
retina  nonsaponifiable  lipids 
obtained 6 h  after intravitreal 
injection  with  [3H]acetate. 
Control  eyes  were  injected 
with 5 ~1 buffer alone; treated 
eyes  received  lovastatin  (100 
Ixg in 5 txl buffer), 1 (B) or 7 
(C) d before [3H]acetate injec- 
tion.  (Upper panels) Endoge- 
nous mass detected by uv ab- 
sorbancc  (214  nm),  with 
relative scale adjusted so as to 
yield  a  full-scale  absorbance 
for  the  cholesterol  peak  (re- 
tention time, 10.8 min); (lower 
panels)  3H  radioactivity  (A, 
74,100 dpm; B,  5,300 dpm; C, 
200 dpm). The elution position 
of  an  authentic  cholesterol 
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from studies with lovastatin in cell culture, because the ef- 
fects of lovastatin can be observed independent  of path- 
ways involved in cell division where the functions of sev- 
eral prenylated proteins are critical (e.g., ras, lamins A  and 
B). The primary effect of lovastatin in the adult retina ap- 
pears to involve the photoreceptor layer and outer limiting 
membrane (Fig. 2, C and D). Over the time course of lova- 
statin-induced  alterations,  there was nearly complete de- 
generation of the photoreceptor inner and outer segments. 
However, the photoreceptor cells apparently did not die, 
since their nuclei and some other organelles remained in- 
tact (Fig. 4 B). Even at timepoints as long as three months 
after a  single  injection,  qualitative  observation indicated 
virtually no change in the relative numbers of intact pho- 
toreceptor nuclei from that observed at 21 d. Within 6 d af- 
Figure 7.  Retinal changes 4 d after intravitreal injection of 50 Ixg 
AFC. Photoreceptor rosettes (r) are essentially identical to those 
observed 6 d after intravitreal injection of lovastatin (cf. Fig. 3 A). 
Bar, 250 ~m. 
ter injection, the photoreceptor nuclei migrated from their 
usual position in the  outer nuclear layer and formed ro- 
settes similar to those observed in retinal dysplasia in hu- 
mans  (Duke-Elder,  1963)  and  other  animals  (Chader  et 
al., 1988; Whitely, 1991). To our knowledge, drug-induced 
dysplastic-like changes in a fully differentiated adult retina 
have not  been  reported,  however,  their  possible natural 
occurrence in the human retina has been observed (Lahav 
et al., 1975).  The relationship, if any, between rosettes oc- 
curring as developmental anomalies and those induced by 
lovastatin remains to be determined. 
The observed histological disruption  induced  by intra- 
vitreal lovastatin could have been due to inhibition of any 
of the branchpoints of the mevalonate pathway as shown 
in Fig.  1. The results reported here coupled with those of 
previous studies allow one to rule out the involvement of all 
branchpoints  except  the  posttranslational  processing  of 
proteins by prenylation. Previous studies employing intra- 
vitreally injected tunicamycin (Fliesler et al., 1984), an in- 
hibitor of dolichol-dependent protein glycosylation, dem- 
onstrated a degenerative effect that is markedly different 
from that obtained with lovastatin. Under suitable condi- 
tions,  intravitreal  tunicamycin  injection  in  adult  animals 
leads to  a  photoreceptor-specific degeneration  that  does 
not  result  in  rosette  formation  or  disruption  of retinal 
stratification.  Hence,  it  is  unlikely  that  the  lovastatin- 
induced degenerative changes are a consequence of pertur- 
bation of dolichylphosphate pools (a significant reduction 
of  which  might  result  in  inhibition  of  protein  glycosy- 
lation). 
Cholesterol  is  a  significant  constituent  of the  plasma 
membrane of most eukaryotic cells, although in photore- 
ceptor disk membranes cholesterol represents <10 mol % 
of the total membrane lipid (Fliesler and Anderson, 1983). 
However, cholesterol appears to be enriched in inner reti- 
nal cell layers, especially in the collective axonal processes 
(for a discussion, see Fliesler and Anderson,  1983).  Thus, 
we evaluated whether or not inhibition of sterol synthesis 
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duced by lovastatin. Intravitreal injection of NB-598 spe- 
cifically inhibited sterol synthesis (Fig. 6) without produc- 
ing  any  alteration  of  retinal  morphology.  This  finding 
suggests a lack of any significant contribution of de novo 
sterol  synthesis disruption  in  the  observed  pathological 
changes  induced by lovastatin. These  results,  taken to- 
gether with those discussed above,  and by a  process  of 
elimination (see Pittler et al.,  1992), previously led us to 
speculate upon an involvement of prenylated proteins in 
the maintenance of retinal cytoarchitecture. 
This presumed involvement of prenylated proteins was 
given further credence by results obtained with intravit- 
real injection of AFC. AFC is a potent competitive inhibi- 
tor of carboxymethylation of prenylated proteins (Volker 
et al.,  1991), the only step in -CAAX processing that is 
reversible (Parish and Rando, 1994). The effects of AFC 
were strikingly similar to those observed with lovastatin 
(cf. Fig. 3 A and Fig. 7), indicating a requirement of one or 
more prenylated/carboxymethylated  proteins in the main- 
tenance of adult retinal cytoarchitecture. A functional role 
for prenylated protein carboxymethylation has been sug- 
gested for visual transduction in  ros  (Prrez-Sala  et  al., 
1991; Ohguro et al.,  1991; Parish and Rando, 1994),  for 
modulation of insulin secretion in islet cells (Metz et al., 
1993),  for agonist-receptor-mediated signal transduction 
in platelets (Akbar et al.,  1993), for fMLP-induced signal 
transduction in neutrophils (Philips et al.,  1993),  and for 
efficient membrane  binding  and  function  of  the  small 
GTP-binding protein ras (Hancock et al., 1991). While it is 
clear that AFC does inhibit the carboxymethyltransferase 
in vitro, its mechanism of action in vivo is  less certain. 
AFC was shown to inhibit chemotaxis of macrophages in a 
manner inconsistent with inhibition of carboxymethyla- 
tion (Scheer and Gierschik, 1993). Using a series of farne- 
sylcysteine derivatives it was shown that analogues that do 
not inhibit the methyltransferase can still block superoxide 
release in neutrophils (Ding et al.,  1994) and platelet ag- 
gregation (Ma et al., 1994). It was suggested that AFC may 
act to alter heterotrimeric G-protein 13~/function (Ding et 
al., 1994), perhaps by interfering with protein-protein in- 
teractions requiring a  carboxymethylated prenylcysteine. 
While the exact mechanism of action of AFC remains to 
be established, it is accepted that AFC affects the function 
of prenylated protein, and thus our results with AFC sup- 
port the participation of prenylated protein in the mainte- 
nance of adult retinal structure. 
Protein prenylation is a  permanent covalent modifica- 
tion that occurs immediately after polypeptide synthesis 
(Goldstein and  Brown,  1990; Rando,  1992).  Thus,  only 
prenylated proteins that turn over in less than 24  h  are 
likely to be candidates for producing the lovastatin-induced 
changes within the observed time course. Therefore, we 
propose that one or more of the several previously identi- 
fied prenylated proteins in adult rat retina (Anant et al., 
1992) are involved in the lovastatin/AFC-induced effects. 
Four of these proteins are photoreceptor specific (cGMP 
phosphodiesterase a  and 13 subunits, transducin ~/subunit, 
rhodopsin kinase) and function in phototransduction, and 
at least three are small, ras-like GTP-binding proteins. A 
null mutation in the rod cGMP phosphodiesterase 13 sub- 
unit in mice (Pittler and Baehr, 1991) or dogs (Suber et al., 
1993)  leads to photoreceptor degeneration, but does not 
mimic the lovastatin effect. Defects in other photoreceptor 
specific proteins, including rhodopsin and peripherin/rds, 
which are both integral membrane proteins, also lead to 
photoreceptor degeneration (Humphries et al., 1992; Kaji- 
wara et al., 1992), without initially effecting other retinal 
cell types or forming rosettes. It is expected that the effects 
of mutations in rhodopsin kinase or transducin ~/-subunit 
are also unlikely to mimic the morphologic effects induced 
by lovastatin. It cannot be ruled out that inhibition of func- 
tion of quantitatively minor or unknown prenylated pro- 
teins is responsible for the lovastatin- and AFC-induced 
morphologic  changes;  however,  we  consider  the  small 
GTP-binding proteins to be the most likely candidates in 
the etiology of the induced degeneration. 
Several reports have now clearly shown a  role for the 
small GTP-binding proteins of the rho class in the modula- 
tion of the actin cytoskeleton (for review see Nobes and 
Hall, 1994; also see the Introduction). A functional role for 
small GTP-binding proteins in phototransduction has also 
been suggested in squid and bovine photoreceptors (Wie- 
land et al., 1990; Petrov et al., 1994) and Limulus photore- 
ceptors (Stieve et al., 1992).  Small GTP-binding proteins 
of the rab family are critical for the intracellular transport 
of rhodopsin-containing vesicles (Deretic and Papermas- 
ter,  1993).  Since  lovastatin  and  AFC  could  inhibit  the 
function of several different GTP-binding proteins (as well 
as  several  other  prenylated  proteins)  in  many  diverse 
pathways, it is likely that the observed effects are pleiotro- 
pic. The loss of outer segments could be due to inhibition 
of rabs required for vesicle transport of rhodopsin, an im- 
portant structural component of disk membranes (Sung et 
al., 1991), while the loss of stratification could be due to in- 
hibition of rho function required for proper microfilament 
organization. Nonetheless, our results are the first to draw 
attention to the structural role of prenylated proteins in 
promoting and maintaining normal retinal cytoarchitecture. 
The morphological changes observed upon intravitreal 
injection  of lovastatin  or  AFC  are  consistent  with  the 
model for maintenance of retinal cytoarchitecture as pro- 
posed by Madreperla and Adler (1989). In this model, op- 
posing forces provided by microtubule and microfilament 
networks function to maintain retinal structural integrity. 
If one force component is severed or greatly reduced in 
numbers (i.e., microfilament arrays), as we propose may 
be the case in the lovastatin and AFC treatments, then a 
dramatic movement of cells might result, due to the con- 
tinuing unopposed force provided by the  other compo- 
nent. The early time points of lovastatin treatment indi- 
cate gross movements of cells (see Fig. 2, C-F) that may be 
occurring as microfilament networks (with their associated 
tensile strengths) dissolve. Over time and due to the per- 
sistence of lovastatin, more and more of the microfilament 
arrays break down with eventual complete loss of retinal 
cytoarchitecture (Fig. 3, C-D). We are currently focusing 
on identifying the prenylated proteins that are presumed 
responsible for the observed lovastatin and AFC-induced 
pathologic effects, and on evaluating which cytoskeletal el- 
ements are affected. 
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